FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Barnett

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Anatomy

Hematopoietic Stem Cells

Co-author Network

Publications

TOP 3
Yasser R Abou Mourad; Michael J Barnett; Rahul Bhargava; Hélène Bruyère; Donna L Forrest; Tanya Gillian; Stephen H Nantel; Thomas J Nevill; Cynthia L Toze; John D Shepherd
Normal Karyotype CALLA-Positive Adult Pre-B ALL: Dismal Outcome With Chemotherapy for Patients With Loss/Gain of ABL1 and/or BCR FISH Signals.
Min Chen; Donna DeGeer; Allen Eaves; Connie J Eaves; Donna L Forrest; Paolo Gallipoli; Tessa L Holyoake; Heather Jorgensen; Damian Lai; K Lambie; Helen Nakamoto; James Paul; Ashley Ringrose; Kyi Min Saw; Ivan Sloma; Jon Stobo; Ali Turhan; Hui Mi Wang; Ralph Arlinghaus; Michael J Barnett; Matthew Chan; Xiaoyan Jiang
Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex.
Cynthia L Toze; Sean S Young; Clayton A Smith; Kevin W Song; Heather J Sutherland; Yasser R Abou Mourad; Michael J Barnett; Raewyn C Broady; Joseph Michael Connors; Chinmay B Dalal; Donna L Forrest; Tanya L Gillan; Donna E Hogge; Stephen H Nantel; Sujaatha Narayanan; Thomas J Nevill; Maryse M Power; John D Shepherd
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Barnett (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yasser R Abou Mourad; Michael J Barnett; Rahul Bhargava; Hélène Bruyère; Donna L Forrest; Tanya Gillian; Stephen H Nantel; Thomas J Nevill; Cynthia L Toze; John D Shepherd
Normal Karyotype CALLA-Positive Adult Pre-B ALL: Dismal Outcome With Chemotherapy for Patients With Loss/Gain of ABL1 and/or BCR FISH Signals.
Clinical lymphoma, myeloma & leukemia 2013;13(3):281-6.
2013: Min Chen; Donna DeGeer; Allen Eaves; Connie J Eaves; Donna L Forrest; Paolo Gallipoli; Tessa L Holyoake; Heather Jorgensen; Damian Lai; K Lambie; Helen Nakamoto; James Paul; Ashley Ringrose; Kyi Min Saw; Ivan Sloma; Jon Stobo; Ali Turhan; Hui Mi Wang; Ralph Arlinghaus; Michael J Barnett; Matthew Chan; Xiaoyan Jiang
Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex.
Journal of the National Cancer Institute 2013;105(6):405-23.
2012: Cynthia L Toze; Sean S Young; Clayton A Smith; Kevin W Song; Heather J Sutherland; Yasser R Abou Mourad; Michael J Barnett; Raewyn C Broady; Joseph Michael Connors; Chinmay B Dalal; Donna L Forrest; Tanya L Gillan; Donna E Hogge; Stephen H Nantel; Sujaatha Narayanan; Thomas J Nevill; Maryse M Power; John D Shepherd
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.
British journal of haematology 2012;158(2):174-85.
2012: Adisak Tantiworawit; Cynthia L Toze; Yasser R Abou-Mourad; Michael J Barnett; Raewyn C Broady; Donna E Hogge; Stephen H Nantel; Sujaatha Narayanan; Thomas J Nevill; Maryse M Power; John D Shepherd; Kevin W Song; Heather J Sutherland; Donna L Forrest
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy.
Leukemia & lymphoma 2012;53(7):1321-6.
2010: Heather A Leitch; Jocelyn M Chase; Trisha A Goodman; Hatoon Ezzat; Meaghan D Rollins; Dominic H C Wong; Maha Badawi; Chantal S Leger; Khaled M Ramadan; Michael J Barnett; Lynda M Foltz; Linda M Vickars
Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy.
Hematological oncology 2010;28(1):40-8.
2010: Y R Abou-Mourad; B C Lau; Michael J Barnett; Donna L Forrest; Donna E Hogge; Stephen H Nantel; Thomas J Nevill; John D Shepherd; C A Smith; Kevin W Song; Heather J Sutherland; Cynthia L Toze; Julye C Lavoie
Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.
Bone marrow transplantation 2010;45(2):295-302.
2009: Thomas J Nevill; John D Shepherd; Heather J Sutherland; Yasser R Abou Mourad; Julye C Lavoie; Michael J Barnett; Stephen H Nantel; Cynthia L Toze; Donna E Hogge; Donna L Forrest; Kevin W Song; Maryse M Power; Janet Nitta; Yunfeng Dai; Clayton A Smith
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(2):205-13.
2009: Donna L Forrest; Shannon Trainor; Ryan R Brinkman; Michael J Barnett; Donna E Hogge; Thomas J Nevill; John D Shepherd; Stephen H Nantel; Cynthia L Toze; Heather J Sutherland; Kevin W Song; Julye C Lavoie; Maryse M Power; Yasser Abou-Mourad; Clayton A Smith
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels.
Leukemia research 2009;33(2):271-5.
2008: K M Ramadan; Joseph Michael Connors; A J Al-Tourah; Kevin W Song; Randy D Gascoyne; Michael J Barnett; Thomas J Nevill; John D Shepherd; Stephen H Nantel; Heather J Sutherland; Donna L Forrest; Donna E Hogge; Julye C Lavoie; Y R Abou-Mourad; Mukesh Chhanabhai; Nicholas J Voss; Ryan R Brinkman; C A Smith; Cynthia L Toze
Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results.
Bone marrow transplantation 2008;42(9):601-8.
2007: John Kuruvilla; John D Shepherd; Heather J Sutherland; Thomas J Nevill; Janet Nitta; Alan Le; Donna L Forrest; Donna E Hogge; Julye C Lavoie; Stephen H Nantel; Cynthia L Toze; Clayton A Smith; Michael J Barnett; Kevin W Song
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(8):925-31.
2007: T Y Halim; Kevin W Song; Michael J Barnett; Donna L Forrest; Donna E Hogge; Stephen H Nantel; Thomas J Nevill; John D Shepherd; Clayton A Smith; Heather J Sutherland; Cynthia L Toze; Julye C Lavoie
Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(7):1246-52.
2007: Bakul I Dalal; Helene Bruyere; Michael J Barnett
Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
British journal of haematology 2007;137(5):385.
2007: Kevin W Song; Michael J Barnett; Randy D Gascoyne; Mukesh Chhanabhai; Donna L Forrest; Donna E Hogge; Julye C Lavoie; Stephen H Nantel; Thomas J Nevill; John D Shepherd; Clayton A Smith; Heather J Sutherland; Cynthia L Toze; Nicholas J Voss; Joseph Michael Connors
Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(3):535-40.
2007: G Gallagher; Mukesh Chhanabhai; Kevin W Song; Michael J Barnett
Unusual presentation of precursor T-cell lymphoblastic lymphoma: involvement limited to breasts and skin.
Leukemia & lymphoma 2007;48(2):428-30.
2006: Yulia Lin; Hélène Bruyère; Douglas E Horsman; Tapio Pantzar; Michael J Barnett; Donna E Hogge; Thomas J Nevill; Stephen H Nantel; Heather J Sutherland; Cynthia L Toze; John D Shepherd; Julye C Lavoie; Kevin W Song; Clayton A Smith; Donna L Forrest
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.
Cancer genetics and cytogenetics 2006;170(1):16-23.
2006: M J Greenwood; Matthew D Seftel; C Richardson; D Barbaric; Michael J Barnett; Helene Bruyere; Donna L Forrest; Douglas E Horsman; C Smith; K Song; Heather J Sutherland; Cynthia L Toze; Thomas J Nevill; Stephen H Nantel; Donna E Hogge
Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia.
Leukemia & lymphoma 2006;47(7):1245-52.
2006: Kevin W Song; Michael J Barnett; Randy D Gascoyne; Douglas E Horsman; Donna L Forrest; Donna E Hogge; Julye C Lavoie; Stephen H Nantel; Thomas J Nevill; John D Shepherd; Clayton A Smith; Heather J Sutherland; Nicholas J Voss; Cynthia L Toze; Joseph Michael Connors
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma.
British journal of haematology 2006;133(6):634-7.
2006: Asha Johny; Kevin W Song; Stephen H Nantel; Julye C Lavoie; Cynthia L Toze; Donna E Hogge; Donna L Forrest; Heather J Sutherland; Alan Le; Janet Nitta; Michael J Barnett; Clayton A Smith; John D Shepherd; Thomas J Nevill
Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(4):480-9.
2005: Donna L Forrest; Donna E Hogge; Thomas J Nevill; Stephen H Nantel; Michael J Barnett; John D Shepherd; Heather J Sutherland; Cynthia L Toze; Clayton A Smith; Julye C Lavoie; Kevin W Song; Nicholas J Voss; Randy D Gascoyne; Joseph Michael Connors
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7994-8002.
2005: Cynthia L Toze; A Galal; Michael J Barnett; John D Shepherd; Eibhlin Conneally; Donna E Hogge; Stephen H Nantel; Thomas J Nevill; Heather J Sutherland; Joseph Michael Connors; Nicholas J Voss; Thomas L Kiss; Hans A Messner; Julye C Lavoie; Donna L Forrest; Kevin W Song; C A Smith; Jeff Lipton
Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease.
Bone marrow transplantation 2005;36(9):825-30.
2005: Richard T Doocey; Cynthia L Toze; Joseph Michael Connors; Thomas J Nevill; Randy D Gascoyne; Michael J Barnett; Donna L Forrest; Donna E Hogge; Julye C Lavoie; Stephen H Nantel; John D Shepherd; Heather J Sutherland; Nicholas J Voss; Clayton A Smith; Kevin W Song
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.
British journal of haematology 2005;131(2):223-30.
2005: Julye C Lavoie; Joseph Michael Connors; Gordon L Phillips; Donna Reece; Michael J Barnett; Donna L Forrest; Randy D Gascoyne; Donna E Hogge; Stephen H Nantel; John D Shepherd; Clayton A Smith; Kevin W Song; Heather J Sutherland; Cynthia L Toze; Nicholas J Voss; Thomas J Nevill
High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver.
Blood 2005;106(4):1473-8.
2005: Kevin W Song; Peter Mollee; Donna E Hogge; Vikas Gupta; Michael J Barnett; Donna L Forrest; Julye C Lavoie; Thomas J Nevill; Stephen H Nantel; John D Shepherd; Clay A Smith; Heather J Sutherland; Cynthia L Toze; Michael Crump; Armand Keating
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission.
Leukemia & lymphoma 2005;46(4):525-31.
2005: Wolfgang Eisterer; Xiaoyan Jiang; Oliver Christ; Hanno Glimm; K H Lee; E Pang; K Lambie; G Shaw; Tessa L Holyoake; AL Petzer; C Auewarakul; Michael J Barnett; Connie J Eaves; Allen Eaves
Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.
Leukemia 2005;19(3):435-41.
2004: Cynthia L Toze; Michael J Barnett; Joseph Michael Connors; Randy D Gascoyne; Nicholas J Voss; Stephen H Nantel; Thomas J Nevill; John D Shepherd; Heather J Sutherland; Julye C Lavoie; Donna L Forrest; Kevin W Song; Donna E Hogge
Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation.
British journal of haematology 2004;127(3):311-21.
2003: Donna L Forrest; Thomas J Nevill; Sheldon C Naiman; Alan Le; DA Brockington; Michael J Barnett; Julye C Lavoie; Stephen H Nantel; Kevin W Song; John D Shepherd; Heather J Sutherland; Cynthia L Toze; J H Davis; Donna E Hogge
Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis.
Bone marrow transplantation 2003;32(9):915-23.
2003: Haytham Khoury; Bakul I Dalal; Thomas J Nevill; Douglas E Horsman; Michael J Barnett; John D Shepherd; Cynthia L Toze; Eibhlin Conneally; Heather J Sutherland; Donna E Hogge; Stephen H Nantel
Acute myelogenous leukemia with t(8;21)--identification of a specific immunophenotype.
Leukemia & lymphoma 2003;44(10):1713-8.
2002: Dawn I Warkentin; Joel B Epstein; Lara M Campbell; Judy G Yip; Victoria C Cox; Allison Ransier; Michael J Barnett; Fawziah Marra
Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients.
The Annals of pharmacotherapy 2002;36(10):1525-31.
2002: Cynthia L Toze; Michael J Barnett
Allogeneic haemopoietic stem cell transplantation for non-Hodgkin's lymphoma.
Best practice & research. Clinical haematology 2002;15(3):481-504.
2002: Matthew D Seftel; J Lavoie; Michael J Barnett; Eibhlin Conneally
Treatment of lymphoid malignancies with non-myeloablative stem cell transplantation.
Hematology (Amsterdam, Netherlands) 2002;7(3):151-5.
2002: Matthew D Seftel; Michael J Barnett
Hematopoietic stem cell transplantation: the Vancouver experience.
Hematology (Amsterdam, Netherlands) 2002;7(3):145-9.
2002: Yves Chalandon; Michael J Barnett; Douglas E Horsman; Eibhlin Conneally; Stephen H Nantel; Thomas J Nevill; Janet Nitta; John D Shepherd; Heather J Sutherland; Cynthia L Toze; Donna E Hogge
Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(8):435-43.
2000: Donna Reece; DA Brockington; Gordon L Phillips; Michael J Barnett; Hans G Klingemann; Stephen H Nantel; Heather J Sutherland; John D Shepherd
Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
Bone marrow transplantation 2000;26(6):621-6.
2000: C A Lohrisch; Thomas J Nevill; Michael J Barnett; Donna E Hogge; Joseph Michael Connors; Paul Keown; R D Gascoyne
Development of a biologically distinct EBV-related lymphoproliferative disorder following autologous bone marrow transplantation for an EBV-negative post-renal allograft Burkitt's lymphoma.
Leukemia & lymphoma 2000;39(1-2):195-201.
2000: K G McCaul; Thomas J Nevill; Michael J Barnett; Cynthia L Toze; C J Currie; Heather J Sutherland; Eibhlin Conneally; John D Shepherd; Stephen H Nantel; Donna E Hogge; Hans G Klingemann
Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin.
Journal of hematotherapy & stem cell research 2000;9(3):367-74.
2000: Tim H Brümmendorf; Tessa L Holyoake; Nathalie Rufer; Michael J Barnett; M Schulzer; Connie J Eaves; Allen Eaves; P M Lansdorp
Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry.
Blood 2000;95(6):1883-90.
2000: Cynthia L Toze; John D Shepherd; Joseph Michael Connors; Nicholas J Voss; Randy D Gascoyne; Donna E Hogge; Hans G Klingemann; Stephen H Nantel; Thomas J Nevill; Gordon L Phillips; Donna Reece; Heather J Sutherland; Michael J Barnett
Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia.
Bone marrow transplantation 2000;25(6):605-12.
2000: Donna E Hogge; K Lambie; Heather J Sutherland; W Barrett Benny; Bakul I Dalal; C Currie; Michael J Barnett; Allen Eaves; Connie J Eaves
Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant.
Bone marrow transplantation 2000;25(6):589-98.
2000: Cynthia L Toze; John D Shepherd; Joseph Michael Connors; Nicholas J Voss; Randy D Gascoyne; Donna E Hogge; Hans G Klingemann; Stephen H Nantel; Thomas J Nevill; Gordon L Phillips; Donna Reece; Heather J Sutherland; Eibhlin Conneally; Michael J Barnett
Allografting for indolent lymphoid neoplasms.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():59-61.
1999: Donna Reece; Thomas J Nevill; A Sayegh; John Spinelli; DA Brockington; Michael J Barnett; Hans G Klingemann; Joseph Michael Connors; Stephen H Nantel; John D Shepherd; Heather J Sutherland; Nicholas J Voss; Randall Fairey; Susan E O'Reilly; Gordon L Phillips
Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease.
Bone marrow transplantation 1999;23(11):1131-8.
1998: Donna L Forrest; Thomas J Nevill; Douglas E Horsman; DA Brockington; Henry Fung; Cynthia L Toze; Eibhlin Conneally; Donna E Hogge; Heather J Sutherland; Stephen H Nantel; John D Shepherd; Michael J Barnett
Bone marrow transplantation for adults with acute leukaemia and 11q23 chromosomal abnormalities.
British journal of haematology 1998;103(3):630-8.
1998: I N Micallef; Mukesh Chhanabhai; Randy D Gascoyne; John D Shepherd; Henry Fung; Stephen H Nantel; Cynthia L Toze; Hans G Klingemann; Heather J Sutherland; Donna E Hogge; Thomas J Nevill; Alan Le; Michael J Barnett
Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience.
Bone marrow transplantation 1998;22(10):981-7.
1998: Donna L Forrest; Douglas E Horsman; C L Jensen; B R Berry; Bakul I Dalal; Michael J Barnett; Stephen H Nantel
Myelodysplastic syndrome with hypereosinophilia and a nonrandom chromosomal abnormality dic(1;7): confirmation of eosinophil clonal involvement by fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1998;107(1):65-8.
1998: Thomas J Nevill; Henry Fung; John D Shepherd; Douglas E Horsman; Stephen H Nantel; Hans G Klingemann; Donna L Forrest; Cynthia L Toze; Heather J Sutherland; Donna E Hogge; Sheldon C Naiman; Alan Le; DA Brockington; Michael J Barnett
Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation.
Blood 1998;92(6):1910-7.
1998: D R Simpson; Thomas J Nevill; John D Shepherd; Henry Fung; Douglas E Horsman; Stephen H Nantel; Linda M Vickars; Heather J Sutherland; Cynthia L Toze; Donna E Hogge; Hans G Klingemann; Sheldon C Naiman; Michael J Barnett
High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation.
Bone marrow transplantation 1998;22(3):259-64.
1998: S R Jackson; Martin Tweeddale; Michael J Barnett; John Spinelli; Heather J Sutherland; Donna Reece; Hans G Klingemann; Stephen H Nantel; Henry Fung; Cynthia L Toze; Gordon L Phillips; John D Shepherd
Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors.
Bone marrow transplantation 1998;21(7):697-704.
1998: Allen Eaves; Michael J Barnett; L Ponchio; Johanne Cashman; AL Petzer; Connie J Eaves
Differences between normal and CML stem cells: potential targets for clinical exploitation.
Stem cells (Dayton, Ohio) 1998;16 Suppl 1():77-83; discussion 89.
1997: Donna L Forrest; Bakul I Dalal; Sheldon C Naiman; Douglas E Horsman; B R Berry; M I Parslow; C P Singh; W Barrett Benny; Michael J Barnett
Testicular relapse of acute promyelocytic leukemia after allogeneic BMT.
Bone marrow transplantation 1997;20(8):689-90.
1997: Bakul I Dalal; V Wu; Michael J Barnett; Douglas E Horsman; John Spinelli; Sheldon C Naiman; John D Shepherd; Stephen H Nantel; Donna Reece; Heather J Sutherland; Hans G Klingemann; Gordon L Phillips
Induction failure in de novo acute myelogenous leukemia is associated with expression of high levels of CD34 antigen by the leukemic blasts.
Leukemia & lymphoma 1997;26(3-4):299-306.
1997: Cynthia L Toze; Michael J Barnett; Sheldon C Naiman; Douglas E Horsman
Trisomy 14 is a non-random karyotypic abnormality associated with myeloid malignancies.
British journal of haematology 1997;98(1):177-85.
1997: AL Petzer; Connie J Eaves; Michael J Barnett; Allen Eaves
Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia.
Blood 1997;90(1):64-9.
1997: JR Heggie; M Wu; R B Burns; C S Ng; Henry Fung; G Knight; Michael J Barnett; John Spinelli; L Embree
Validation of a high-performance liquid chromatographic assay method for pharmacokinetic evaluation of busulfan.
Journal of chromatography. B, Biomedical sciences and applications 1997;692(2):437-44.
1996: AL Petzer; C J Eaves; Peter M Lansdorp; Luisa Ponchio; Michael J Barnett; Allen Eaves
Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia.
Blood 1996;88(6):2162-71.
1995: Henry Fung; John D Shepherd; Sheldon C Naiman; Michael J Barnett; Donna Reece; Douglas E Horsman; Stephen H Nantel; Heather J Sutherland; John Spinelli; Hans G Klingemann
Acute monocytic leukemia: a single institution experience.
Leukemia & lymphoma 1995;19(3-4):259-65.
1995: Donna Reece; Michael J Barnett; John D Shepherd; Donna E Hogge; R J Klasa; Stephen H Nantel; Heather J Sutherland; Hans G Klingemann; Randall Fairey; N J Voss
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Blood 1995;86(2):451-6.
1995: S R Jackson; Michael J Barnett; O Keller; Stephen H Nantel; Gordon L Phillips
Recovery from rhabdomyolysis after allogeneic BMT: report of a case with speculation on causation.
Bone marrow transplantation 1995;15(5):803-4.
1995: R J Cuthbert; John D Shepherd; Stephen H Nantel; Michael J Barnett; Donna Reece; Hans G Klingemann; K W Chan; John Spinelli; Heather J Sutherland; Gordon L Phillips
Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
Clinical and investigative medicine. Médecine clinique et experimentale 1995;18(2):122-30.
1995: John D Shepherd; Randy D Gascoyne; Michael J Barnett; J D Coghlan; Gordon L Phillips
Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia.
Bone marrow transplantation 1995;15(4):639-41.
1995: H Tezcan; Michael J Barnett; C N Bredeson; Donna Reece; John D Shepherd; Bakul I Dalal; Douglas E Horsman; Hans G Klingemann; Stephen H Nantel; John Spinelli
Treatment of acute promyelocytic leukemia in patients presenting at Vancouver General Hospital from 1983 to 1992.
Leukemia & lymphoma 1995;16(5-6):439-44.
1995: Gordon L Phillips; Thomas J Nevill; John Spinelli; Stephen H Nantel; Hans G Klingemann; Michael J Barnett; John D Shepherd; K W Chan; Jacinta Meharchand; Heather J Sutherland
Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation.
Bone marrow transplantation 1995;15(2):213-9.
1995: Donna Reece; John D Shepherd; Hans G Klingemann; Heather J Sutherland; Stephen H Nantel; Michael J Barnett; John Spinelli; Gordon L Phillips
Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantation.
Bone marrow transplantation 1995;15(1):117-23.
1994: Hans G Klingemann; C J Eaves; Michael J Barnett; A C Eaves; Donna E Hogge; Stephen H Nantel; E Reece; John D Shepherd; Heather J Sutherland; Gordon L Phillips
Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administration.
Bone marrow transplantation 1994;14(3):389-96.
1994: Michael J Barnett; C J Eaves; Gordon L Phillips; Randy D Gascoyne; Donna E Hogge; Douglas E Horsman; R K Humphries; Hans G Klingemann; P M Lansdorp; Stephen H Nantel
Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study.
Blood 1994;84(3):724-32.
1994: Donna Reece; Joseph Michael Connors; John Spinelli; Michael J Barnett; Randall Fairey; Hans G Klingemann; Stephen H Nantel; S O'Reilly; John D Shepherd; Heather J Sutherland
Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy.
Blood 1994;83(5):1193-9.
1993: John D Shepherd; Michael J Barnett; Joseph Michael Connors; John Spinelli; Heather J Sutherland; H G Kingemann; Stephen H Nantel; Donna Reece; C J Currie; Gordon L Phillips
Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphoma.
Bone marrow transplantation 1993;12(6):591-6.
1993: Michael J Barnett; C J Eaves; Gordon L Phillips; Donna E Hogge; Hans G Klingemann; P M Lansdorp; Stephen H Nantel; Donna Reece; John D Shepherd; Heather J Sutherland
Autografting in chronic myeloid leukemia with cultured marrow: update of the Vancouver Study.
Stem cells (Dayton, Ohio) 1993;11 Suppl 3():64-6.
1993: C J Eaves; Johanne Cashman; N C Zoumbos; Michael J Barnett; Allen Eaves
Biological strategies for the selective manipulation of normal and leukemic stem cells.
Stem cells (Dayton, Ohio) 1993;11 Suppl 3():109-21.
1993: Michael J Barnett; C M Coppin; N Murray; Thomas J Nevill; Donna Reece; Hans G Klingemann; John D Shepherd; Stephen H Nantel; Heather J Sutherland; Gordon L Phillips
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.
British journal of cancer 1993;68(3):594-8.
1993: C N Bredeson; Michael J Barnett; Douglas E Horsman; Bakul I Dalal; J Ragaz; Gordon L Phillips
Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary.
Leukemia & lymphoma 1993;11(1-2):141-5.
1993: C J Eaves; Michael J Barnett; Allen Eaves
In vitro culture of bone marrow cells for autografting in CML.
Leukemia 1993;7 Suppl 2():S126-9.
1993: Cynthia L Toze; Michael J Barnett; Hans G Klingemann
Response of therapy-related myelodysplasia to low-dose interleukin-2.
Leukemia 1993;7(3):463-5.
1993: John D Shepherd; Donna Reece; Michael J Barnett; Hans G Klingemann; Stephen H Nantel; Heather J Sutherland; Gordon L Phillips
Induction therapy for acute myelogenous leukemia in patients over 60 years with intermediate-dose cytosine arabinoside, mitoxantrone and etoposide.
Leukemia & lymphoma 1993;9(3):211-5.
1993: Donna Reece; Michael J Barnett; Joseph Michael Connors; Hans G Klingemann; Susan E O'Reilly; John D Shepherd; Heather J Sutherland; Gordon L Phillips
Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.
Bone marrow transplantation 1993;11(2):139-46.
1993: Donna Reece; M B Elmongy; Michael J Barnett; Hans G Klingemann; John D Shepherd; Gordon L Phillips
Chemotherapy with high-dose cytosine arabinoside and mitoxantrone for poor-prognosis myeloid leukemias.
Cancer investigation 1993;11(5):509-16.
1992: R J Cuthbert; Gordon L Phillips; Michael J Barnett; Stephen H Nantel; Donna Reece; John D Shepherd; Hans G Klingemann
Anti-interleukin-2 receptor monoclonal antibody (BT 563) in the treatment of severe acute GVHD refractory to systemic corticosteroid therapy.
Bone marrow transplantation 1992;10(5):451-5.
1992: Thomas J Nevill; John D Shepherd; Donna Reece; Michael J Barnett; Stephen H Nantel; Hans G Klingemann; Gordon L Phillips
Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMT.
Bone marrow transplantation 1992;10(5):445-50.
1992: Michael J Barnett; C J Eaves; G L Phillips; Donna E Hogge; Hans G Klingemann; P M Lansdorp; Stephen H Nantel; Donna Reece; John D Shepherd; Heather J Sutherland
Autografting in chronic myeloid leukemia with cultured marrow.
Leukemia 1992;6 Suppl 4():118-9.
1992: C Udomsakdi; C J Eaves; B Swolin; D S Reid; Michael J Barnett; Allen Eaves
Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(13):6192-6.
1992: Thomas J Nevill; M H Tirgan; H J Deeg; Hans G Klingemann; Donna Reece; John D Shepherd; Michael J Barnett; Gordon L Phillips
Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantation.
Bone marrow transplantation 1992;9(5):349-54.
1992: C J Eaves; Heather J Sutherland; C Udomsakdi; Peter M Lansdorp; S J Szilvassy; C C Fraser; R Keith Humphries; Michael J Barnett; G L Phillips; Allen Eaves
The human hematopoietic stem cell in vitro and in vivo.
Blood cells 1992;18(2):301-7.
1991: Gordon L Phillips; Michael J Barnett; M C Brain; K W Chan; L B Huebsch; Hans G Klingemann; Jacinta Meharchand; Donna Reece; W B Rybka; John D Shepherd
Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
Bone marrow transplantation 1991;8(6):477-87.
1991: John D Shepherd; L E Pringle; Michael J Barnett; Hans G Klingemann; Donna Reece; Gordon L Phillips
Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(11):2016-20.
1991: Donna Reece; D A Frei-Lahr; John D Shepherd; K Dorovini-Zis; Randy D Gascoyne; D A Graeb; John Spinelli; Michael J Barnett; Hans G Klingemann; Geoffrey P Herzig
Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin.
Bone marrow transplantation 1991;8(5):393-401.
1991: Gordon L Phillips; John D Shepherd; Michael J Barnett; P M Lansdorp; Hans G Klingemann; John Spinelli; Thomas J Nevill; K W Chan; Donna Reece
Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(10):1880-8.
1991: Donna Reece; Michael J Barnett; Joseph Michael Connors; Randall Fairey; Joseph W Fay; John P Greer; Geoffrey P Herzig; Roger H Herzig; Hans G Klingemann; C F LeMaistre
Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(10):1871-9.
1991: Thomas J Nevill; Michael J Barnett; Hans G Klingemann; Donna Reece; John D Shepherd; Gordon L Phillips
Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(7):1224-32.
1991: Gordon L Phillips; Donna Reece; John D Shepherd; Michael J Barnett; R A Brown; D A Frei-Lahr; Hans G Klingemann; B J Bolwell; John Spinelli; Roger H Herzig
High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults.
Blood 1991;77(7):1429-35.
1991: Michael J Barnett; Heather J Sutherland; A C Eaves; Donna E Hogge; R K Humphries; Hans G Klingemann; P M Lansdorp; Gordon L Phillips; Donna Reece; John D Shepherd
Human hematopoietic stem cells in long-term culture: quantitation and manipulation.
Bone marrow transplantation 1991;7 Suppl 1():70.
1990: A G Turhan; R Keith Humphries; C J Eaves; Michael J Barnett; G L Phillips; D K Kalousek; H G Klingemann; P L Lansdorp; D E Reece; John D Shepherd
Detection of breakpoint cluster region- negative and nonclonal hematopoiesis in vitro and in vivo after transplantation of cells selected in cultures of chronic myeloid leukemia marrow.
Blood 1990;76(11):2404-10.
1990: Hans G Klingemann; Michael J Barnett; Donna Reece; John D Shepherd; Gordon L Phillips
Use of an immunoglobulin preparation enriched for IgM (Pentaglobin) for the treatment of acute graft-versus-host disease.
Bone marrow transplantation 1990;6(3):199-202.
1989: Gordon L Phillips; Donna Reece; Michael J Barnett; Joseph Michael Connors; Joseph W Fay; G P Herzig; R H Herzig; Hans G Klingemann; John D Shepherd; Steven Neil Wolff
Allogeneic marrow transplantation for refractory Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(8):1039-45.
1988: John D Shepherd; T B Shore; Donna Reece; Michael J Barnett; Hans G Klingemann; N A Buskard; Gordon L Phillips
Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease.
Bone marrow transplantation 1988;3(6):553-8.